Executive Profile*

Michael Myers Ph.D.

This person is connected to 0 board members in 0 different organizations across 3 different industries.

52

$439,134

Background*

Dr. Michael Myers, Ph.D., has been Executive Vice President of Flamel since May 11, 2000. Dr. Myers is responsible for its Sales, Marketing and Business Development. He has been the Head of Portfolio Operations at Innocoll AG (formerly Innocoll GmbH) since December 08, 2014 and served as its Member of Management Board. He served as the Chief Executive Officer of Innocoll AG from 2003 to December 08, 2014, and also served as its President and Chairman of Management Board. ... Dr. Myers served as an Executive Vice President and President of the Pharmaceutical Division at Biovail Technologies Limited (formerly, Fuisz Technologies Ltd.) since April 1996. He joined Fuisz Technologies Ltd. in November 1995 as Vice President, Sustained Release. At Fuisz, he led day to day and strategic operations, in addition to business development activities, R&D, manufacturing quality operations and regulatory affairs. From 1987 to 1995, he served for Elan Corporation PLC, a leading drug delivery company, as Head of Pharmaceutical Development. He also served senior R&D positions at Kos Pharmaceuticals. He served as a Director of Innocoll, Inc. Dr. Myers received his Ph.D. in Organic Chemistry and B.Sc. from University College, Cork, Ireland.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.